Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Inland Real Estate Reveals JV Acquisition Of Seven Properties - Quick Facts

RELATED NEWS
Trade IRC now with 

Inland Real Estate Corp. (IRC: Quote) said Monday it has contributed $15 million to its joint venture with Inland Private Capital Corp. to acquire for $40.8 million two portfolios that include seven single-tenant retail properties.

The company said the joint venture acquired a portfolio of two free-standing stores net leased to CVS Pharmacy and one asset that is net leased to Walgreens, for a purchase price of $17.1 million. The venture also acquired for $23.7 million a second portfolio which includes one asset that is net leased to CVS, plus three properties that are net leased to Walgreens.

Simultaneous with the closing, the joint venture placed loans totaling $25.8 million on the portfolios, the company said.

Click here to receive FREE breaking news email alerts for Inland Real Estate Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.